Abstract

Praziquantel (PZQ) is the drug of choice for treatment of the neglected tropical disease schistosomiasis. Although the drug has been extensively used over several decades and its metabolism well studied (several oxidative metabolites are known from literature), the knowledge of the complete structure of some of its metabolites remains elusive. Conventional techniques, such as nuclear magnetic resonance or liquid chromatography mass spectrometry were used in the past to investigate phase I and phase II metabolites of PZQ. These techniques are either limited to provide the complete molecular structure (liquid chromatography mass spectrometry) or require large amount of sample material (NMR), which are not always available when in vitro systems are used for investigation of the metabolites. In this study, we describe new structures of S-PZQ metabolites generated in vitro from human liver microsomes using the crystalline sponge method. After chromatographic separation and purification of the oxidative metabolites, ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry analysis was conducted to narrow down the position of oxidation to a certain part of the molecule. To determine the exact position of hydroxylation, singe-crystal X-ray diffraction analysis of the crystalline sponges and absorbed analyte was used to identify the structure of S-PZQ and its metabolites. The crystalline sponge method allowed for complete structure elucidation of the known metabolites S-trans-4'-hydroxy-PZQ (M1), S-cis-4'-hydroxy-PZQ (M2) and S-/R-11b-hydroxy-PZQ (M6) as well as the unknown metabolites S-9-hydroxy-PZQ (M3) and S-7-hydroxy-S-PZQ (M4). For comparison of structural elucidation techniques, one metabolite (M3) was additionally analyzed using NMR. SIGNIFICANCE STATEMENT: The information content of the metabolic pathway of praziquantel is still limited. The crystalline sponge method allowed the complete structural elucidation of three known and two unknown metabolites of S-praziquantel, using only trace amounts of analyte material, as demonstrated in this study.

Highlights

  • Schistosomiasis is a neglected tropical disease caused by a parasitic flatworm of the genus Schistosoma and affects, with a high prevalence in Africa, almost 240 million people worldwide

  • The supernatant was evaporated to dryness and resolubilized in acetonitrile/water (20:80). 100 μl aliquots were used for purification and fractionation by high performance liquid chromatography coupled with mass spectrometry (HPLC-MS)

  • ultra-performance liquid chromatography (UPLC)-quadrupole timeof-flight mass spectrometry (qTOF) analysis of S-PZQ metabolites prepared by incubation with human liver microsomes (HLM)

Read more

Summary

Introduction

Schistosomiasis is a neglected tropical disease caused by a parasitic flatworm of the genus Schistosoma and affects, with a high prevalence in Africa, almost 240 million people worldwide. Enantioselective transformation of R-PZQ and S-PZQ has been explored in various studies, showing different metabolic profiles for both enantiomers (Wang et al, 2014; Vendrell-Navarro et al, 2020, Park et al, 2021). Two more metabolites have been described as 8-hydroxy PZQ and 11b-hydroxy PZQ by isolation from human urine and in vitro recombinant human P450 reactions, using NMR for data analysis (Schepmann and Blaschke, 2001; Vendrell-Navarro et al, 2020). Despite the advantage of LC-MS techniques to reach high sensitivity for sample analysis from in vitro origin, these techniques failed to identify the complete structure of metabolites

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call